Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Senate Republicans released their version of the Trump administration’s “One Big Beautiful Bill Act” on Monday with a few ...

Making prescription drugs more affordable was a key goal of the Inflation Reduction Act (IRA). However, most Medicare ...

Senate Majority Leader John Thune (R-S.D.) and Vice President Vance struck a deal Saturday night with a group of Senate conservatives who want bigger Medicaid spending cuts to save President Trump’s ...

Medicare "Part E" would be self-sustaining, funded by premiums, and available through all state and federal health exchanges.

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...